Summit Trail Advisors LLC Raises Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Summit Trail Advisors LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,602 shares of the medical equipment provider’s stock after buying an additional 1,150 shares during the quarter. Summit Trail Advisors LLC’s holdings in Intuitive Surgical were worth $3,446,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the company. M.E. Allison & CO. Inc. purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth $449,000. Seilern Investment Management Ltd purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth $82,517,000. Exome Asset Management LLC increased its position in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after buying an additional 1,069 shares in the last quarter. Sycomore Asset Management increased its position in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after buying an additional 4,079 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its position in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after buying an additional 525 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ISRG has been the topic of several recent analyst reports. Bernstein Bank upped their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Leerink Partners increased their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Robert W. Baird increased their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Finally, The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at approximately $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,940 shares of company stock valued at $3,346,964 over the last quarter. 0.90% of the stock is owned by insiders.

Intuitive Surgical Stock Up 2.2 %

ISRG stock opened at $595.70 on Tuesday. The business has a fifty day moving average of $554.85 and a two-hundred day moving average of $514.80. The stock has a market cap of $212.18 billion, a price-to-earnings ratio of 92.93, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.